ISSN : 1226-9654
Memory is labile immediately upon acquisition and becomes stable over time, and this process is called memory consolidation. If retrieved, previously-consolidated memory becomes labile again and re-consolidates. Thus, memory can be altered by intervening in either the consolidation or reconsolidation process. Propranolol is one promising drug that can block memory consolidation and reconsolidation. The present article reviewed basic research on memory consolidation and reconsolidation, and clinical trials of propranolol for the prevention and treatment of posttraumatic stress disorder. Clinical studies are currently mixed with positive and negative results, and future research is warranted on boundary conditions in which memory reconsolidation occurs. Finally, ethical issues of using memory-altering drugs are discussed.
American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (5th ed.) Arlington, VA: American Psychiatric Publishing.
American Psychological Association (2017). Clinical practice guideline for the treatment of PTSD in adults. Washington, DC: Author.
Bell, J. A. (2007). Preventing post-traumatic stress disorder or pathologizing bad memories? American Journal of Bioethics, 7(9), 29-30.
Bradley, R., Greene, J., Russ, E., Dutra, L., & Westen, D. (2005). A multidimensional meta-analysis of psychotherapy for PTSD. American Journal of Psychiatry, 162, 214-227.
Brunet, A., Orr, S. P., Tremblay, J., Robertson, K., Nader, K., & Pitman, R. K. (2008). Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. Journal of Psychiatric Research, 42, 503-506.
Brunet, A., Poundja, J., Tremblay, J., Bui, É., Thomas É., Orr, S. P., . . . Pitman, R. K. (2011). Trauma reactivation under the influence of propranolol decreases posttraumatic stress symptoms and disorder: 3 open-label trials. Journal of Clinical Psychopharmacology, 31, 547-550.
Brunet, A., Thomas, É., Saumier, D., Ashbaugh, A. R., Azzoug, A., Pitman, R. K., . . . Tremblay, J. (2014). Trauma reactivation plus propranolol is associated with durably low physiological responding during subsequent script-driven traumatic imagery. Canadian Journal of Psychiatry, 59, 228-232.
Chandavarkar, R., Sangha, S., & Khalil, S. (2016). Resolution of flashbacks of PTSD with propranolol: A case report. Progress in Neurology and Psychiatry, 20(2), 10-13.
Chandler, J. A., Mogyoros, A., Rubio, T. M., & Racine, E. (2013). Another look at the legal and ethical consequences of pharmacological memory dampening: The case of sexual assault. Journal of Law, Medicine & Ethics, 41, 859-871.
Henry, M., Fishman, J. R., & Youngner, S. J. (2007). Propranolol and the prevention of Post-traumatic stress disorder: Is it wrong to erase the “sting” of bad memories? The American Journal of Bioethics, 7(9), 12-20.
Hoge, E. A., Worthington, J. J., Nagurney, J. T., Chang, Y., Kay, E. B., Feterowski, C. M., . . . Pitman, R. K. (2012). Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery. CNS Neuroscience & Therapeutics, 18, 21-27.
Kindt, M., & van Emmerik, A. (2016). New avenues for treating emotional memory disorders: Towards a reconsolidation intervention for posttraumatic stress disorder. Therapeutic Advances in Psychopharmacology, 6, 283-295.
Kindt, M., Soeter, M., & Vervliet, B. (2009). Beyond extinction: erasing human fear responses and preventing the return of fear. Nature Neuroscience, 12, 256-258.
Management of Posttraumatic Stress Working Group (2010). VA/DoD clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder. Washington, DC: Department of Veterans Affairs, Department of Defense.
McGaugh, J. L. (2000). Memorya century of consolidation. Science, 287, 248-251.
McGaugh, J. L. (2003). Memory and Emotion. New York, NY: Columbia University Press.
McGaugh, J. L. (2015). Consolidating memories. Annual Review of Psychology, 66, 1-24.
McGaugh, J. L., & Roozendaal, B. (2009). Drug enhancement of memory consolidation: historical perspective and neurobiological implications. Psychopharmacology, 202, 3-14.
McGhee, L. L., Maani, C. V., Garza, T. H., DeSocio, P. A., Gaylord, K. M., & Black, I. H. (2009). The effect of propranolol on posttraumatic stress disorder in burned service members. Journal of Burn Care & Research, 30, 92-97.
Menzies, R. P. (2012). Propranolol, traumatic memories, and amnesia: A study of 36 cases. Journal of Clinical Psychiatry, 73, 129-130.
Nader, K., Schafe, G. E., & LeDoux, J. E. (2000). Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature, 406, 722-726.
Orr, S. P., Metzger, L. J., & Pitman, R. K. (2002). Psychophysiology of post-traumatic stress disorder. Psychiatric Clinics of North America, 25, 271-293.
Pitman, R. K. (1989). Post-traumatic stress disorder, hormones, and memory. Biological Psychiatry, 26, 221-223.
Pitman, R. K., Sanders, K. M., Zusman, R. M., Healy, A. R., Cheema, F., Lasko, N. B., Cahill, L., & Orr, S. P. (2002). Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biological Psychiatry, 51, 189-142.
President’s Council on Bioethics (2003). Beyond therapy: Biotechnology and the pursuit of happiness. Washington, DC: Government Printing Office.
Ressler, K. J., & Mayberg, H. S. (2007). Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nature Neuroscience, 10, 1116-1124.
Saladin, M. E., Gray, K., Abbott, T., LaRowe, S., McRae-Clark, A., DeSantis, S., . . . Brady, K. T. (2014). Post-retrieval propranolol may alter reconsolidation of trauma memory in individuals with PTSD and comorbid alcohol dependence. Drug & Alcohol Dependence, 140, e193, doi: 10.1016/j.drugalcdep.2014.02.538
Schiller, D., Monfils, M.-H., Raio, C. M., Johnson, D. C., LeDoux, J. E., & Phelps, E. A. (2010). Preventing the return of fear in humans using reconsolidation update mechanisms, Nature, 463, 49-54.
Schroyens, N., Beckers, T., & Kindt, M. (2017). In search for boundary conditions of reconsolidation: A failure of fear memory interference, Frontiers in Behavioral Neuroscience, 11, 65. doi: 10.3389/fnbeh.2017.00065
Stein, M. B., Kerridge, C., Dimsdale, J. E., & Hoyt, D. B. (2007). Pharmacotherapy to prevent PTSD: Results from a randomized controlled proof-of-concept trial in physically injured patients. Journal of Traumatic Stress, 20, 923-932.
Vaiva, G., Ducrocq, F., Jezequel, K., Averland, B., Lestavel, P., Brunet, A., & Marmar, C. R. (2003). Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biological Psychiatry, 54, 947-949.
Walker, M. P., Brakefield, T., Hobson, J. A., & Stickgold, R. (2003). Dissociable stages of human memory consolidation and reconsolidation. Nature, 425, 616-620.
Wood, N. E., Rosasco, M. L., Suris, A. M., Spring, J. D., Marin, M.-F., Lasko, N. B., . . . Pitman, R. K. (2015). Pharmacological blockade of memory reconsolidation in posttraumatic stress disorder: Three negative psychophysiological studies. Psychiatry Research, 225, 31-39.